Rational Design, Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G‐Quadruplex Binding Properties

Molecular modeling studies carried out with experimental DNA models with the sequence d[AG3(T2AG3)3] suggest that the introduction of a net positive charge onto the side chain of a series of fluorenone carboxamides can improve G‐quadruplex binding. The terminal morpholino moiety was replaced with a novel N‐methylmorpholinium cation starting from two 4‐carboxamide compounds. A different substitution on the fluorenone ring was also investigated and submitted to the same quaternarization process. All compounds were analyzed for their DNA binding properties by competition dialysis methods. In vitro antiproliferative tests were carried out against two different tumor cell lines. Docking experiments were conducted by including all four known human repeat unit G‐quadruplex DNA sequences (27 experimentally determined conformations) against the most active fluorenone derivatives. The results of theoretical, biophysical, and in vitro experiments indicate two novel derivatives as lead compounds for the development of a new generation of G‐quadruplex ligands with greater potency and selectivity.

[1]  Stephen Neidle,et al.  Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.

[2]  Roger A. Jones,et al.  Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence , 2007, Nucleic acids research.

[3]  R. Wellinger,et al.  The terminal DNA structure of mammalian chromosomes , 1997, The EMBO journal.

[4]  T. Creighton Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.

[5]  M. Stevens,et al.  Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.

[6]  Sarah W. Burge,et al.  Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.

[7]  D. Sun,et al.  G-quadruplex DNA binding by a series of carbocyanine dyes. , 2001, Bioorganic & medicinal chemistry letters.

[8]  K. Dubrana,et al.  Telomeres and telomerase as targets for anticancer drug development. , 2006, Critical reviews in oncology/hematology.

[9]  W. Delano The PyMOL Molecular Graphics System (2002) , 2002 .

[10]  D. Patel,et al.  Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. , 1993, Structure.

[11]  B. Guyen,et al.  Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. , 2004, Organic & biomolecular chemistry.

[12]  S. Alcaro,et al.  Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. , 2007, Bioorganic & medicinal chemistry letters.

[13]  S. Alcaro,et al.  9-Fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II , 2004 .

[14]  Stephen Neidle,et al.  The structures of quadruplex nucleic acids and their drug complexes. , 2009, Current opinion in structural biology.

[15]  S. Neidle,et al.  Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. , 2007, Bioorganic & medicinal chemistry letters.

[16]  Jean-Louis Mergny,et al.  Targeting telomeres and telomerase. , 2008, Biochimie.

[17]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[18]  S. Neidle,et al.  2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.

[19]  B. Gatto,et al.  Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences. , 2008, Bioorganic & medicinal chemistry.

[20]  Stefano Alcaro,et al.  A “quasi‐flexible” automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation , 2000 .

[21]  Roger A. Jones,et al.  Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation , 2007, Nucleic acids research.

[22]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[23]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[24]  Marco Pierini,et al.  “Quasi flexible” automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of ΔΔG of complexation and 1H‐NMR NOE correlation , 2007, J. Comput. Chem..

[25]  M. Caraglia,et al.  The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? , 2008, The Journal of investigative dermatology.

[26]  S. Mackay,et al.  Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase. , 2002, Bioorganic & medicinal chemistry.

[27]  Charles A Laughton,et al.  Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. , 2002, Journal of medicinal chemistry.

[28]  Stephen Neidle,et al.  Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Neidle,et al.  1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.

[30]  L. Kèlland,et al.  Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. , 2005, European journal of cancer.

[31]  S. Neidle,et al.  Natural and synthetic G-quadruplex interactive berberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.

[32]  Stefano Alcaro,et al.  GRID‐based Pharmacophore Models: Concept and Application Examples , 2006 .

[33]  Anna Artese,et al.  Rational Approaches to Anticancer Drug Design/in silico Drug Development , 2008 .

[34]  O. Fedoroff,et al.  NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.

[35]  A. Phan,et al.  Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.

[36]  P. Lord,et al.  A Strategy for Primary High Throughput Cytotoxicity Screening in Pharmaceutical Toxicology , 2000, Pharmaceutical Research.

[37]  P J Goodford,et al.  A search for specificity in DNA-drug interactions. , 1994, Journal of Molecular Graphics.

[38]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[39]  J. Mergny,et al.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Wheelhouse,et al.  Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. , 2001, Journal of medicinal chemistry.

[41]  G. Chang,et al.  Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .

[42]  J. Chaires,et al.  The tail of the telomere. , 2008, Journal of the American Chemical Society.

[43]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[44]  E. De Pauw,et al.  Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis. , 2003, Biochemistry.

[45]  S. Neidle,et al.  Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. , 1999, Anti-cancer drug design.

[46]  Dik-Lung Ma,et al.  5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. , 2008, Journal of medicinal chemistry.